A Study To Evaluate The Safety And Effectiveness Of A New Antiseizure Drug Called Xen1101
Posted Date: Jun 12, 2019
- Investigator: Brian Moseley
- Specialties: Epilepsy, Neurology
- Type of Study: Drug
The purpose of this study is to investigate the safety and effectiveness of a new antiseizure drug called XEN1101 in patients with partial (aka focal) onset seizures that haven't responded to 1-3 other antiseizure drugs.
Male And Female Patients Between 18 And 75 Years Of Age, Diagnosed With Partial (Aka Focal) Epilepsy And Still Having 4 Or More Partial Seizures Per Month Despite Treatment With 1-3 Other Antiseizure Drugs.
For More Information: